{
  "id": "SCR-LIP-000508",
  "statement": "In a systematic review of 16 studies covering 4537 lipedema patients, reported depression prevalence ranged from 23% to 59.2% (40% in the largest study, n=1362), with mean PHQ-9 scores of 10.8-12.2 (mild-to-moderate depression) and a suggested dose-response association with lipedema stage.",
  "statement_pt": "Em uma revisão sistemática de 16 estudos abrangendo 4537 pacientes com lipedema, a prevalência relatada de depressão variou de 23% a 59,2% (40% no maior estudo, n=1362), com escores médios no PHQ-9 de 10,8-12,2 (depressão leve a moderada) e sugestão de relação dose-resposta com o estadiamento do lipedema.",
  "claim_type": "clinical_association",
  "context": {
    "population": "patients with lipedema (4537 across 16 studies)",
    "condition": "lipedema",
    "exposure": "lipedema diagnosis",
    "comparator": "general population and obese patients",
    "outcome": "depression prevalence and severity (PHQ-9)",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "moderate",
  "evidence": [
    {
      "title": "Lipedema and depression - A systematic review",
      "ref": "DOI:10.1016/j.jpsychores.2025.112306",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "moderate",
      "year": 2025,
      "amato_authored": false,
      "quote": "Prevalências de depressão reportadas entre 23% e 59,2% Maior estudo (n=1362) reportou prevalência de 40% para depressão Vários estudos encontraram associação positiva entre depressão e estadiamento do lipedema — sugestivo de relação dose-resposta",
      "extraction_confidence": "high",
      "note": "Systematic review reporting elevated depression prevalence and severity in lipedema patients versus general population, with a stage-dependent association, directly addressing the depression component of the question.",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "All specific figures in the statement (16 studies, 4537 patients, 23%-59.2% prevalence range, 40% in largest study n=1362, PHQ-9 scores 10.8-12.2, dose-response with stage) are directly present in the abstract.",
        "date": "2026-11-17"
      }
    }
  ],
  "relations": [],
  "gaps": "Auto-ingested single source; not yet human-reviewed.",
  "primary_amato_source": null,
  "curators": [],
  "provenance": {
    "auto": true,
    "engine": "anthropic/claude-opus-4.8",
    "question": "SQ-LIP-000020",
    "source": "library",
    "ingested": "2026-11-17"
  },
  "created": "2026-11-17",
  "updated": "2026-11-17",
  "history": [
    {
      "date": "2026-11-17",
      "event": "created",
      "detail": "auto-ingested for SQ-LIP-000020"
    },
    {
      "date": "2026-11-20",
      "event": "consolidated",
      "detail": "SQ-LIP-000020: evidence moved to SCR-LIP-000692"
    },
    {
      "date": "2026-11-20",
      "event": "consolidated",
      "detail": "SQ-LIP-000042: evidence moved to SCR-LIP-000785"
    }
  ],
  "license": "CC-BY-4.0",
  "superseded_by": [
    "SCR-LIP-000692",
    "SCR-LIP-000785"
  ],
  "status": "superseded",
  "answers_questions": [],
  "url": "https://scientificclaims.org/c/SCR-LIP-000508.html"
}